Product Information
LOXAPINE 5 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.2979 per EA under NDC 00591036901. Its NADAC has been published 608 times since Nov 28, 2013.
FDA first approved this application on Jun 15, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591036901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LOXAPINE SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA072204FDA Approved
6/15/1988
TE Code
AB
On Market Since
6/15/1988
Price Statistics
The NADAC for LOXAPINE 5 MG CAPSULE has been published 608 times since Nov 28, 2013, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2979 per EA |
|---|---|
| All-time high | $0.5044 (Dec 13, 2023) |
| All-time low | $0.2375 (Jan 22, 2025) |
| 52-week high | $0.4135 |
| 52-week low | $0.2949 |
| Median price | $0.3500 |
| Average price | $0.3664 |
| Largest weekly change | +34.3% (Jan 19, 2022) |
| Weeks tracked | 608 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOXAPINE 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOXAPINE 5 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.2979 per EA (NDC 00591036901), effective Aug 19, 2026.
How has the price of LOXAPINE 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOXAPINE 5 MG CAPSULE has declined 11.0%. It has been tracked across 608 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOXAPINE 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOXAPINE 5 MG CAPSULE has ranged from a low of $0.2375 (Jan 22, 2025) to a high of $0.5044 (Dec 13, 2023), with a median of $0.3500 per EA.
Are there cheaper alternatives to LOXAPINE 5 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOXAPINE 5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LOXAPINE 5 MG CAPSULE?
LOXAPINE 5 MG CAPSULE (NDC 00591036901) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.